Dr. Howard Fine MD, Dr. Jonathan Prenner MD, and Dr. Paul Hahn MD all from NJRetina were selected to deliver podium talks at the prestigious Retina Society, held in Boston, MA in October 2017. Dr. Jonathan Prenner (photo) devised and presented a novel technique for secondary posterior chamber intraocular lens insertion that is transconjunctival and sutureless. Dr. Howard Fine presented his research to elucidate the source of post-operative inflammation using high performance liquid chromatography of indocyanine green dye. Dr. Paul Hahn described the treatment of myopic choroidal neovascularization with ranibizumab injections in the Phase III Radiance Trial.
NJRetina’s Doctors: Howard Fine MD, Jonathan Prenner MD, and Paul Hahn MD at Retina Society Meeting in Boston, October 2017
Bookmark the permalink.